Usability Sciences Corporation Launches WebIQ Pharma An Intelligent Survey Tool That Allows Pharma Sites to Measure and Improv | TradingMarkets.com  New ETF Book by Larry Connors Click here to read more
 Usability Sciences Corporation Launches WebIQ Pharma An Intelligent Survey Tool That Allows Pharma Sites to Measure and Improv
Posted on: Tue, 23 Mar 2010 06:00:00 EDT
, ,  Do you know when to trade  &  ?Check for a  from TradingMarkets  IRVING, Texas, March 23, 2010 /PRNewswire via COMTEX/ Usability Sciences Corporation launches its WebIQ Pharma offering, an intelligent survey solution that provides pharmaceutical sites with metrics to answer critical questions about site and content effectiveness, to increase return on investment ROI .Usability Sciences has provided usability and user experience research to Merck  , Eli Lilly  , Novartis  and Ortho McNeil for over ten years.Pharmaceutical brands build websites primarily to drive drug adoption.The brands want site visitors who have never tried the drug to make appointments with their doctors to discuss the drug.The brands want visitors who have been prescribed the drug to keep taking it and get their prescriptions refilled.Most importantly, the brands need to know which content areas drive the desired behaviors and which content areas do not.Establishing the link between visitor response to the site and the content that determined their response has heretofore been extremely difficult.WebIQ Pharma makes it simple and, compared to the labor intensive alternatives, extremely cost effective."WebIQ Pharma employs intelligent survey technology and intelligent dashboards in delivering this patented solution," said Usability Sciences President Jeff Schueler."The intelligent survey technology allows the brand to ask questions of site visitors based on where they went on the site and what content they saw.WebIQ Pharma dashboards, rather than deliver more 'dumb' data, provide answers to the site's key business questions." Usability Sciences developed the methodology specifically for the pharmaceutical industry, where brand sites often carry high costs but generate relatively low traffic.WebIQ Pharma arms the brand with a continuous stream of answers to drug adoption questions and allows them to constantly improve site stickiness, conversion, and ROI.WebIQ Pharma is flexible and can be customized to fit any brand's needs and preferences in terms of options and pricing.More information can be found at www.usabilitysciences.com/solutions/webiq/webiq pharma or by contacting the company directly at info@usabilitysciences.com.About Usability Sciences: With more than 20 years of experience in the usability and user experience arena, Usability Sciences has developed an industry leading portfolio of research methodologies that delivers robust and actionable results to its Fortune 500 client base.For more information about Usability Sciences' service offerings, go to www.usabilitysciences.com or call 1 800 820 1222.Press Release Contact Information: Jeff Schueler Media Liaison Usability Sciences Corporation 972 550 1599 jschueler@usabilitysciences.com This release was issued through WebWire R .For more information visit http://www.webwire.com.SOURCE Usability Sciences Corporation For full details on Novartis Ag Ads NVS .Novartis Ag Ads NVS has Short Term PowerRatings at TradingMarkets.Details on Novartis Ag Ads NVS Short Term PowerRatings is available at For full details on Merck & Co MRK .Merck & Co MRK has Short Term PowerRatings at TradingMarkets.Details on Merck & Co MRK Short Term PowerRatings is available at For full details on Eli Lilly & Company LLY .Eli Lilly & Company LLY has Short Term PowerRatings at TradingMarkets.Details on Eli Lilly & Company LLY Short Term PowerRatings is available at Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day.Join us for our  20 minute tele seminars during the week.Thursday April 29 12:30 PM Hear What Kevin Haggerty Sees in the Stock Market Today!Wednesday April 28 01:00 PM Hear What Gary Kaltbaum Sees in the Stock Market Today!* Attendance is strictly limited and are filled on a first come, first served basis. 